Ömer Hazman Selected Research

Ömer Hazman Research Topics

6	Inflammation (Inflammations) 04/2024 - 01/2015
2	Neoplasms (Cancer) 06/2018 - 04/2016
2	Weight Gain 11/2016 - 01/2015
2	Obesity 11/2016 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 08/2015 - 01/2015
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Adenocarcinoma 01/2021
1	Renal Insufficiency (Renal Failure) 01/2017
1	Hyperinsulinism (Hyperinsulinemia) 11/2016
1	Insulin Resistance 11/2016
1	Ischemia 05/2016
1	Acute Kidney Injury (Acute Renal Failure) 05/2016
1	Lung Diseases (Lung Disease) 04/2016
1	Necrosis 04/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 08/2015
1	Diabetes Complications 01/2015
1	Reperfusion Injury 06/2014
1	Spinal Cord Ischemia 06/2014
1	Heroin Dependence (Heroin Abuse) 01/2011

3	AntioxidantsIBA 05/2016 - 01/2011
2	CytokinesIBA 01/2021 - 04/2016
2	Cisplatin (Platino)FDA LinkGeneric 06/2018 - 01/2017
2	safranalIBA 08/2015 - 01/2015
2	Streptozocin (Streptozotocin)FDA Link 08/2015 - 01/2015
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	ArbutinIBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	boraxIBA 06/2018
1	Caspase 1 (ICE Protease)IBA 06/2018
1	Endoplasmic Reticulum Chaperone BiPIBA 06/2018
1	boric acid (boron oxide hydroxide)IBA 06/2018
1	CreatinineIBA 01/2017
1	Urea (Carbamide)FDA LinkGeneric 01/2017
1	crocinIBA 11/2016
1	salicylhydroxamic acid (SHAM)IBA 05/2016
1	PhytochemicalsIBA 04/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Carrier Proteins (Binding Protein)IBA 06/2014
1	interleukin-18 binding proteinIBA 06/2014
1	ElementsIBA 01/2011
1	EnzymesIBA 01/2011
1	Vitamin E FDA LinkGeneric 01/2011
1	MelatoninIBA 01/2011
1	Heroin (Diamorphine)IBA 01/2011